Circadian Genes and Breast Cancer in African Americans and Caucasians

非裔美国人和白种人的昼夜节律基因与乳腺癌

• 批准号: 8636314
• 负责人: Ann Hsing
• 金额: $ 7.42万
• 依托单位: CANCER PREVENTION INSTIT OF CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-04 至 2016-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8636314
• 关键词: Affect; African; African American; Breast Cancer Prevention; Cancer Etiology; Carcinogens; Caucasians; Caucasoid Race; Chinese People; Circadian Rhythms; DNA Repair; Data; Diagnosis; Epidemiologic Studies; Estrogen Receptor 2; Estrogen Receptors; Estrogen receptor negative; Genes; Genetic; Hour; Human; Incidence; International Agency for Research on Cancer; Link; Logistic Regressions; Malignant Neoplasms; Malignant neoplasm of prostate; Meta-Analysis; Pattern; Population; Population Attributable Risks; Race; Receptor Signaling; Regression Analysis; Risk; Role; Single Nucleotide Polymorphism; Testing; Time; Variant; Woman; base; cancer risk; caucasian American; cohort; genetic variant; genome wide association study; high risk; malignant breast neoplasm; novel; outcome forecast; prevent; progesterone receptor negative; public health relevance; risk variant; shift work; tumor

DESCRIPTION (provided by applicant): African American women are disproportionally affected by more aggressive subtypes of breast cancer, such as estrogen receptor (ER)- and triple negative cancers, and are more likely to have worse prognoses than their Caucasian counterparts. Reasons for this racial disparity are unclear. In 2007, shift work that involves disruption of the circadian rhythm, the body's diurnal pattern of timing that operates on about a 24-hour cycle, was classified as a probable carcinogen to humans (group 2A) by the International Agency for Research on Cancer based primarily on findings from breast cancer studies. How the body responds to circadian disruptions is due in part to variations in a set of 30 genes that regulate the circadian rhythm (circadian genes). These circadian genes can influence ER signaling and DNA damage repair, factors that have been linked to a higher risk of breast cancer. Previous studies have also shown that the distribution patterns of variations in the circadian genes differ between African and non-African populations. We hypothesize that variations in the 30 circadian genes are associated with breast cancer risk in African American and Caucasian women. We further hypothesize that the relationship between circadian gene variants and aggressive breast cancer subtypes differ between African Americans and Caucasians, thereby contributing partly to the disparity of incidence rates of the aggressive breast cancer subtypes seen between these two racial groups. We will test these hypotheses by conducting a large study of breast cancer using existing genetic data on African American women from the African American Breast Cancer Consortium (AABC; 3,200 cases, including 1,000 ER-negative cases, and 2,800 controls with data on 7,400 variants in the 30 genes) and Caucasian women from the Breast and Prostate Cancer Cohort Consortium (BPC3; 2,200 ER-negative cases and 2,200 controls with data on 3,800 variants in the 30 genes) for a comprehensive statistical analysis. Using data from the AABC, we will determine whether circadian gene variants are associated with risk of breast cancer [total and ER-negative and ER- /progesterone receptor (PR)-negative subtypes] in African American women (Aim 1); we focus on ER- and ER-/PR-negative subtypes because numbers of triple negative cases are small. Similarly, using data from BPC3, we will determine whether circadian gene variants are associated with risk of ER- and ER-/PR-negative breast cancers in Caucasian women (Aim 2). Results of the race-specific analysis will be used to determine whether the associations between circadian gene variants (2,500 SNPs typed in both AABC and BPC3 women) and ER- or ER-/PR-negative breast cancers differ between African Americans and Caucasians, thereby contributing partly to the racial disparity of these aggressive breast cancer subtypes (Aim 3). Identifying novel risk variants that can clarify reasons for the observed racial disparity of aggressive breast cancer subtypes between African Americans and Caucasians will be particularly useful for providing important information for developing strategies for breast cancer prevention that might minimize the burden of breast cancer in both racial groups.

描述（由申请人提供）：非裔美国妇女受到更具侵袭性的乳腺癌亚型的影响，如雌激素受体（ER）和三阴性癌症，并且比高加索人更有可能患上更严重的乳腺癌。这种种族差异的原因尚不清楚。2007年，国际癌症研究机构主要根据乳腺癌研究的结果，将涉及昼夜节律（身体以24小时为一个周期运作的昼夜时间模式）中断的轮班工作列为可能对人类致癌的物质（2A组）。身体对昼夜节律紊乱的反应部分是由于一组30个 调节昼夜节律的基因（昼夜节律基因）。这些昼夜节律基因可以影响ER信号传导和DNA损伤修复，这些因素与乳腺癌的高风险有关。以前的研究也表明，非洲人和非非洲人之间的昼夜节律基因变异的分布模式不同。我们假设30个昼夜节律基因的变异与非裔美国人和高加索妇女患乳腺癌的风险有关。我们进一步假设，昼夜节律基因变异和侵袭性乳腺癌亚型之间的关系在非洲裔美国人和高加索人之间存在差异，从而部分导致这两个种族群体之间侵袭性乳腺癌亚型发病率的差异。我们将利用非裔美国人乳腺癌联合会现有的非裔美国妇女的遗传数据进行一项大型乳腺癌研究，以检验这些假设（AABC; 3，200例病例，包括1，000例ER阴性病例，2，800例对照，30个基因中有7，400个变异）和来自乳腺癌和前列腺癌队列联盟的白人女性（BPC 3; 2，200例ER阴性病例和2，200例对照，30个基因中有3，800个变异的数据）进行综合统计分析。使用来自AABC的数据，我们将确定昼夜节律基因变异是否与非裔美国妇女乳腺癌[总和ER阴性和ER/孕激素受体（PR）阴性亚型]的风险相关（目标1）;我们专注于ER和ER/PR阴性亚型，因为三阴性病例的数量很少。同样，使用来自BPC 3的数据，我们将确定昼夜节律基因变异是否与高加索女性ER和ER/PR阴性乳腺癌的风险相关（目标2）。种族特异性分析的结果将用于确定昼夜节律基因变异（AABC和BPC 3女性中的2，500个SNP分型）与ER或ER/PR阴性乳腺癌之间的关联是否在非裔美国人和高加索人之间存在差异，从而部分导致这些侵袭性乳腺癌亚型的种族差异（Aim 3）。识别新的风险变异，可以澄清非洲裔美国人和白人之间观察到的侵袭性乳腺癌亚型种族差异的原因，这将特别有助于为制定乳腺癌策略提供重要信息 这可能会减少两个种族群体中乳腺癌的负担。